Anti-DRAXIN antibody (300-330) {FITC}

Référence NB-22-57642-100

Conditionnement : 100ug

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

General Info

Host: Rabbit
Applications: ELISA/ICC/WB
Reactivity: Bovine/Chicken/Human/Monkey/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-DRAXIN (300-330) is suitable for use in ELISA, Immunocytochemistry and Western Blot research applications.
Clonality: Polyclonal
Conjugation: FITC
Isotype: IgG
Purification: Affinity Purified
Concentration: 0.64 µg/µl
Dilution Range: WB: 1:500-1:1, 000
DB: 1:20, 000-1:50, 000
ELISA: 1:20, 000-1:50, 000
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.

Information

Gene Symbol: DRAXIN
Gene ID: 374946
Uniprot ID: DRAXI_HUMAN
Immunogen Region: 300-330
Immunogen: Synthetic peptide taken within amino acid region 300-330 on C terminal region of Human Draxin protein. Region: NNKCFDDCMC VEGLRCYAKF HRNRRVTRRK

Description

Function Chemorepulsive axon guidance protein required for the development of spinal cord and forebrain commissures. Acts as a chemorepulsive guidance protein for commissural axons during development. Able to inhibit or repel neurite outgrowth from dorsal spinal cord. Inhibits the stabilization of cytosolic beta-catenin (CTNNB1) via its interaction with LRP6, thereby acting as an antagonist of Wnt signaling pathway.
Protein Name Draxin
Dorsal Inhibitory Axon Guidance Protein
Dorsal Repulsive Axon Guidance Protein
Neucrin
Cellular Localisation Secreted
Alternative Antibody Names Anti-Draxin antibody
Anti-Dorsal Inhibitory Axon Guidance Protein antibody
Anti-Dorsal Repulsive Axon Guidance Protein antibody
Anti-Neucrin antibody
Anti-DRAXIN antibody
Anti-C1orf187 antibody
Anti-PSEC0258 antibody
Anti-UNQ3119 antibody
Anti-PRO10268 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance